Table 2.
Summary of the findings of nephropathy in the mitochondrial cytopathy and LBW-related nephropathy patients
| Normal | Mitochondrial cytopathy | LBW-related nephropathy | |
|---|---|---|---|
| mtDNA mutation | No | Yes | No |
| FSGS lesion | No | Yes1 | Yes |
| Glomerular hypertrophy | No | Yes or No | Yes |
| Foot process effacement | No | Yes | Yes |
| Increased mitochondria in podocyte | No | Yes | No |
| GSECs in tubules | No | Yes | Yes |
| COX IV expression in glomeruli | uniform | mosaic pattern | weak (but intense in a few podocytes) |
| COX IV expression in tubules | uniform | partially mosaic pattern | partially mosaic pattern |
1Although the two patients with mitochondrial cytopathy had no FSGS lesions in the glomeruli, the presence of FSGS lesions is a characteristic glomerular change in mitochondrial cytopathy patients, as reported in many previous reports.